Diabetes Clinical Trials in Massachusetts

Showing 201-220 of 301 trials

Hepatic Dysfunction, Vitamin D Status, and Glycemic Control in Diabetes

NCT02132442

This study is designed to study the effect of vitamin D intake on the severity of fatty liver and poor glucose control in patients with type 2 diabetes and fatty liver disease.

Type 2 DiabetesNonalcoholic Fatty Liver DiseaseVitamin D Deficiency

University of Massachusetts, Worcester12 participantsStarted Mar 2014

Worcester, Massachusetts, United States

COMPLETEDPHASE318 miles

A Study of Taspoglutide Versus Pioglitazone in Patients With Type 2 Diabetes

NCT00909597

This double-blind, double-dummy 3 arm study will evaluate the efficacy, safety and tolerability of taspoglutide versus pioglitazone in patients with type 2 diabetes mellitus inadequately controlled with sulfonylurea monotherapy or sulfonylurea plus metformin combination therapy. After an initial screening period, patients will be randomized to one of 3 groups, to receive a)taspoglutide 10mg sc weekly, b)taspoglutide 20mg sc weekly after 4 weeks of taspoglutide 10mg sc weekly or c)pioglitazone 45mg/day po after 4 weeks of pioglitazone 30mg/day po.The anticipated time on study treatment is 24 months, and the target sample size is 500+ individuals.

Diabetes Mellitus Type 2

Hoffmann-La Roche756 participantsStarted May 2009

Buena Park, California, United States • Chino, California, United States • Los Angeles, California, United States +144 more locations

Hepatic Dysfunction, Vitamin D Status, and Glycemic Control in Diabetes

A Study of Taspoglutide Versus Pioglitazone in Patients With Type 2 Diabetes

Diabetes Trials in Other Cities

Efficacy and Safety of Albiglutide in Treatment of Type 2 Diabetes

A Study to Determine the Safety and Efficacy of Albiglutide in Subjects With Type 2 Diabetes

Effect of Diabetes Education During Retinal Ophthalmology Visits on Diabetes Control

Telehealth Intervention for Youth With T1DM

A Study to Evaluate ITCA 650 Compared to Sitagliptin as add-on Therapy for the Treatment of Type 2 Diabetes

Rosiglitazone In Subjects With Type 2 Diabetes Mellitus Who Are Inadequately Controlled On Insulin

A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease

Comparison of TAK-875 to Placebo as an Add-on to Glimepiride in Patients With Type 2 Diabetes

A Study to Determine the Safety and Efficacy of Albiglutide Administered in Combination With Insulin Glargine

A Study of Aleglitazar in Patients With Type 2 Diabetes

24-week Treatment With Lixisenatide in Type 2 Diabetes Insufficiently Controlled With Metformin and Insulin Glargine

GLP-1 Receptor Agonist Lixisenatide (Morning or Evening) in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Metformin

GAPP 2 Survey: Global Attitudes of Patients and Physicians in Insulin Therapy for Type 2 Diabetes Mellitus

Finding a Safe and Effective Dose of Linagliptin in Pediatric Patients With Type 2 Diabetes

Efficacy and Safety of Insulin Aspart vs. Human Insulin During Pregnancy by Women With Type 1 Diabetes

A Study of a GLP-1 Analogue in Patients With Type 2 Diabetes Treated With Metformin.

A Trial Comparing Sequential Addition of Insulin Aspart Versus Further Dose Increase With Insulin Degludec/Liraglutide in Subjects With Type 2 Diabetes Mellitus, Previously Treated With Insulin Degludec/Liraglutide and Metformin and in Need of Further Intensification

A Study of RO5093151 and RO5027838 in Patients With Type 2 Diabetes Mellitus on a Stable Dose of Metformin

Other Conditions in Massachusetts